There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.

ChemSpider 2D Image | Gandotinib | C23H25ClFN7O


  • Molecular FormulaC23H25ClFN7O
  • Average mass469.942 Da
  • Monoisotopic mass469.179321 Da
  • ChemSpider ID25027412

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1229236-86-5 [RN]
3-(4-Chlor-2-fluorbenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amin [German] [ACD/IUPAC Name]
3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine [ACD/IUPAC Name]
3-(4-Chloro-2-fluorobenzyl)-2-méthyl-N-(5-méthyl-1H-pyrazol-3-yl)-8-(4-morpholinylméthyl)imidazo[1,2-b]pyridazin-6-amine [French] [ACD/IUPAC Name]
Imidazo[1,2-b]pyridazin-6-amine, 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)- [ACD/Index Name]

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

PubChem Substance ID 329825761 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      5 Axon Medchem 2554
      H303;H313;H317;H333;H334;H335;H383 Axon Medchem 2554
      no pictogram Axon Medchem 2554
      P101;P102;P103;P260;P262;P263;P264;P270;P280;P304;P312;P350 Axon Medchem 2554
      Warning Axon Medchem 2554
    • Target Organs:

      JAK inhibitor; FLT3 inhibitor; FGFR inhibitor TargetMol T2638
    • Bio Activity:

      JAK MedChem Express HY-13034
      JAK/STAT Signaling MedChem Express HY-13034
      JAK/STAT Signaling; MedChem Express HY-13034
      JAK2(V617F);FLT3;JAK2;JAK1;FLT4;FGFR2;TYK2;JAK3 TargetMol T2638
      LY2784544(gandotinib) is a potent JAK2 inhibitor with IC50 of 3 nM, effective in JAK2V617F(Ki=0.245 nM), 8- and 20-fold selective versus JAK1 and JAK3.; IC5o value: 3 nM [1]; Target: JAK2; in vitro: LY2784544 also inhibits IL-3-activated wild type JAK2 with IC50 of 2.26 ?M. MedChem Express HY-13034
      Tyrosine Kinase/Adaptors; JAK/STAT Signaling TargetMol T2638

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.5±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.700
Molar Refractivity: 124.5±0.5 cm3
#H bond acceptors: 8
#H bond donors: 2
#Freely Rotating Bonds: 6
#Rule of 5 Violations: 0
ACD/LogP: 2.39
ACD/LogD (pH 5.5): 2.26
ACD/BCF (pH 5.5): 21.04
ACD/KOC (pH 5.5): 197.47
ACD/LogD (pH 7.4): 2.92
ACD/BCF (pH 7.4): 96.19
ACD/KOC (pH 7.4): 902.56
Polar Surface Area: 83 Å2
Polarizability: 49.3±0.5 10-24cm3
Surface Tension: 53.0±7.0 dyne/cm
Molar Volume: 322.0±7.0 cm3

Click to predict properties on the Chemicalize site